Improved overall survival in patients developing endocrine toxicity during treatment with nivolumab for advanced non-small cell lung cancer in a prospective study.
Albertelli M, Rossi G, Nazzari E, Genova C, Biello F, Rijavec E, Dal Bello MG, Patti L, Tagliamento M, Barletta G, Morabito P, Boschetti M, Dotto A, Campana D, Ferone D, Grossi F.
Albertelli M, et al. Among authors: rossi g.
J Endocrinol Invest. 2024 Apr 29. doi: 10.1007/s40618-023-02268-0. Online ahead of print.
J Endocrinol Invest. 2024.
PMID: 38683497